John D. Turnidge
#133,060
Most Influential Person Now
John D. Turnidge's AcademicInfluence.com Rankings
John D. Turnidgebiology Degrees
Biology
#8915
World Rank
#12056
Historical Rank
Microbiology
#465
World Rank
#526
Historical Rank
Neuroscience
#1276
World Rank
#1321
Historical Rank
Download Badge
Biology
John D. Turnidge's Degrees
- PhD Microbiology University of Adelaide
- Bachelors Microbiology University of Adelaide
Why Is John D. Turnidge Influential?
(Suggest an Edit or Addition)John D. Turnidge's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. (2006) (1205)
- Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community (2002) (970)
- Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. (1988) (707)
- Susceptibility Test Methods: Dilution and Disk Diffusion Methods* (2015) (549)
- Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. (2005) (536)
- The Pharmacodynamics of β-Lactams (1998) (510)
- Setting and Revising Antibacterial Susceptibility Breakpoints (2007) (483)
- Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 (2019) (333)
- Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. (2006) (329)
- Antimicrobial Use Guidelines for Treatment of Urinary Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases (2011) (269)
- In vivo postantibiotic effect in a thigh infection in neutropenic mice. (1988) (264)
- Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. (2015) (252)
- Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. (2011) (240)
- In Vitro Pharmacodynamic Properties of Colistin and Colistin Methanesulfonate against Pseudomonas aeruginosaIsolates from Patients with Cystic Fibrosis (2001) (238)
- Emergence of Vancomycin-Resistant Enterococci in Australia: Phenotypic and Genotypic Characteristics of Isolates (1998) (226)
- The pharmacodynamics of beta-lactams. (1998) (221)
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document) (2010) (220)
- Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand (2009) (215)
- MIC-based dose adjustment: facts and fables (2018) (207)
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole (2012) (200)
- A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. (1996) (196)
- Control of Fluoroquinolone Resistance through Successful Regulation, Australia (2012) (194)
- Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases). (2014) (194)
- Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models (2009) (192)
- Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. (2011) (192)
- Stability of Colistin and Colistin Methanesulfonate in Aqueous Media and Plasma as Determined by High-Performance Liquid Chromatography (2003) (188)
- Pharmacodynamics and dosing of aminoglycosides. (2003) (187)
- Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. (2003) (184)
- Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia (2013) (184)
- New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection. (2015) (180)
- Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). (2005) (180)
- Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases (2017) (180)
- Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. (2004) (173)
- In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. (2008) (171)
- High Prevalence of Oxacillin-Resistant Staphylococcus aureus Isolates from Hospitalized Patients in Asia-Pacific and South Africa: Results from SENTRY Antimicrobial Surveillance Program, 1998-1999 (2002) (171)
- Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). (2002) (171)
- Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. (2008) (170)
- Genetic Characterization of vanG, a Novel Vancomycin Resistance Locus of Enterococcus faecalis (2000) (169)
- fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. (2010) (161)
- Antibiotic use in animals--prejudices, perceptions and realities. (2003) (159)
- Methicillin‐resistant Staphylococcus aureus in the Australian community: an evolving epidemic (2006) (153)
- Use of High-Performance Liquid Chromatography To Study the Pharmacokinetics of Colistin Sulfate in Rats following Intravenous Administration (2003) (151)
- Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform? (2016) (147)
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document) (2011) (143)
- A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. (2001) (143)
- Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. (2009) (140)
- Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. (2008) (133)
- In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia (2001) (130)
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine (2012) (123)
- Antibiotic use and resistance—proving the obvious (2005) (117)
- Simple Method for Assaying Colistin Methanesulfonate in Plasma and Urine Using High-Performance Liquid Chromatography (2002) (114)
- Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. (1999) (113)
- Pharmacokinetics and Pharmacodynamics of Fluoroquinolones (2012) (112)
- Fusidic acid in vitro activity. (1999) (109)
- Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) position statements on polymyxin B and colistin clinical breakpoints. (2020) (104)
- Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods (2011) (104)
- International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method (2015) (101)
- Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole (2014) (97)
- The postantibiotic effect of antifungal agents against common pathogenic yeasts. (1994) (97)
- First detection of extended-spectrum cephalosporin- and fluoroquinolone-resistant Escherichia coli in Australian food-producing animals. (2015) (95)
- Fusidic Acid Resistance Rates and Prevalence of Resistance Mechanisms among Staphylococcus spp. Isolated in North America and Australia, 2007-2008 (2010) (95)
- Resistance to fusidic acid. (1999) (91)
- Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999. (2003) (90)
- Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment (2011) (87)
- Carbapenemase-producing bacteria in companion animals: a public health concern on the horizon. (2014) (86)
- Reviving old antibiotics. (2015) (85)
- Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method (2013) (84)
- Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. (2012) (83)
- Carbapenem Resistance among Pseudomonas aeruginosa Strains from India: Evidence for Nationwide Endemicity of Multiple Metallo-β-Lactamase Clones (VIM-2, -5, -6, and -11 and the Newly Characterized VIM-18) (2008) (82)
- Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae (1995) (82)
- Regional Resistance Surveillance Program Results for 12 Asia-Pacific Nations (2011) (2013) (82)
- Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. (2002) (79)
- Susceptibility Test Methods: General Considerations (2011) (77)
- Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales (2015) (76)
- Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). (2007) (76)
- Activities of Dalbavancin against a Worldwide Collection of 81,673 Gram-Positive Bacterial Isolates (2009) (75)
- Molecular Epidemiology of Enterococcal Bacteremia in Australia (2014) (74)
- Renal Disposition of Colistin in the Isolated Perfused Rat Kidney (2009) (74)
- Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. (2002) (72)
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document) (2011) (72)
- Consistent global approach on reporting of colistin doses to promote safe and effective use. (2013) (71)
- The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds. (2016) (71)
- Fine-needle aspiration biopsy in diagnosis of soft tissue infections (1985) (71)
- Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008. (2009) (71)
- Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method (2016) (71)
- Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals (1996) (70)
- A risk analysis framework for the long-term management of antibiotic resistance in food-producing animals. (2002) (67)
- Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens (2008) (67)
- The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. (1999) (67)
- Prevalence and Significance of a Negative Extended-Spectrum β-Lactamase (ESBL) Confirmation Test Result after a Positive ESBL Screening Test Result for Isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program (2007) (65)
- Use of empiric antimicrobial therapy in neutropenic fever (2011) (65)
- Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians (2012) (63)
- Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods (2017) (63)
- Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia (1999) (62)
- Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children. (2016) (62)
- Helicobacter pylori resistance to tetracycline (1996) (60)
- Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision (2018) (60)
- Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for the Cryptococcus neoformans-Cryptococcus gattii Species Complex Using the CLSI M27-A3 Broth Microdilution Method (2014) (58)
- Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method (2015) (57)
- Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori. (1995) (57)
- The Pharmacodynamics of b-Lactams (1998) (56)
- The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: Data from the multinational SMARRT Study. (2020) (56)
- Carbapenem-Resistant Isolates of Klebsiella pneumoniae in China and Detection of a Conjugative Plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 Gene (2007) (54)
- Antimicrobial resistance in clinical Escherichia coli isolated from companion animals in Australia. (2017) (53)
- Emergence and epidemiology of vancomycin-resistant enterococci in Australia. (1998) (53)
- Neurological complications of chlamydial infections: case report and review. (1997) (52)
- Phylogenetic diversity, antimicrobial susceptibility and virulence characteristics of phylogroup F Escherichia coli in Australia. (2016) (51)
- Selective inhibition of Biotin Protein Ligase from Staphylococcus aureus* (2012) (51)
- In‐use efficacy of a chlorhexidine in alcohol surgical rub: a comparative study (2004) (50)
- Pharmacodynamics of Doxycycline and Tetracycline against Staphylococcus pseudintermedius: Proposal of Canine-Specific Breakpoints for Doxycycline (2013) (49)
- Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition. (2017) (48)
- Cefazolin and enterobacteriaceae: rationale for revised susceptibility testing breakpoints. (2011) (48)
- Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent (2017) (46)
- Trough Concentrations of Vancomycin: Adult Therapeutic Targets Are Not Appropriate for Children (2012) (45)
- Antimicrobial resistance testing of Helicobacter pylori: A comparison of etest and disk diffusion methods (1997) (44)
- Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy. (1996) (43)
- CLSI微量液体希釈法(M38-A2文書)のカスポファンギン及びアスペルギルス属の野生型MIC分布及び疫学的カットオフ値 (2011) (43)
- Statistical Methods for Establishing Quality Control Ranges for Antibacterial Agents in Clinical and Laboratory Standards Institute Susceptibility Testing (2007) (42)
- Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations. (2007) (42)
- Home‐based treatment of cellulitis with twice‐daily cefazolin (1998) (41)
- Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method (2013) (41)
- Efflux Pump-Driven Antibiotic and Biocide Cross-Resistance in Pseudomonas aeruginosa Isolated from Different Ecological Niches: A Case Study in the Development of Multidrug Resistance in Environmental Hotspots (2020) (39)
- Biotin analogues with antibacterial activity are potent inhibitors of biotin protein ligase. (2012) (39)
- Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapy (1996) (39)
- Surveillance of the current resistance of nosocomial pathogens to antibacterials (1997) (38)
- Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014. (2016) (38)
- Genetic and Molecular Predictors of High Vancomycin MIC in Staphylococcus aureus Bacteremia Isolates (2014) (37)
- What can be done about resistance to antibiotics? (1998) (36)
- Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia. (2006) (36)
- The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008). (2010) (35)
- The induction of Staphylococcus aureus biofilm formation or Small Colony Variants is a strain-specific response to host-generated chemical stresses. (2015) (35)
- Prolonged Growth of a Clinical Staphylococcus aureus Strain Selects for a Stable Small-Colony-Variant Cell Type (2014) (34)
- Impact of Antibiotic Resistance on the Treatment of Sepsis (2003) (33)
- Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. (1992) (33)
- Minim Typing – A Rapid and Low Cost MLST Based Typing Tool for Klebsiella pneumoniae (2012) (33)
- Polymicrobial septicaemia with Pseudomonas aeruginosa and Streptococcus pyogenes following traditional tattooing. (1997) (33)
- The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal. (2020) (33)
- Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002). (2004) (31)
- Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005-06: report from the Australian Group on Antimicrobial Resistance. (2007) (31)
- Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi (2011) (30)
- Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific. (2003) (29)
- 3: Community‐acquired pneumonia (2002) (29)
- Selection of SHV Extended-Spectrum-β-Lactamase-Dependent Cefotaxime and Ceftazidime Resistance in Klebsiella pneumoniae Requires a Plasmid-Borne blaSHV Gene (2007) (29)
- Single-dose antibiotic prophylaxis in contaminated abdominal surgery. (1989) (28)
- Defining the Dosage Units for Colistin Methanesulfonate: Urgent Need for International Harmonization (2006) (28)
- Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro (1996) (28)
- Community-onset Staphylococcus aureus Surveillance Programme annual report, 2012. (2014) (28)
- Risk factors for adverse cutaneous reactions associated with intravenous vancomycin. (1997) (28)
- The Pharmacodynamics of Antimicrobial Agents (2013) (27)
- Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia. (2013) (27)
- Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013. (2014) (27)
- Evaluation of API Campy in comparison with conventional methods for identification of thermophilic campylobacters (1995) (27)
- Disc susceptibility testing for thermomphilic campylobacters (1997) (27)
- Post-antibiotic growth suppression of linezolid against Gram-positive bacteria. (2001) (26)
- Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents. (2009) (26)
- Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2021) (26)
- Precision of Vancomycin and Daptomycin MICs for Methicillin-Resistant Staphylococcus aureus and Effect of Subculture and Storage (2014) (26)
- Prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005: report from the Australian Group on Antimicrobial Resistance. (2007) (26)
- Australian Group on Antimicrobial Resistance Hospital-onset Staphylococcus aureus Surveillance Programme annual report, 2011. (2013) (26)
- Antimicrobial susceptibility of Staphylococcus aureus and molecular epidemiology of meticillin-resistant S. aureus isolated from Australian hospital inpatients: Report from the Australian Group on Antimicrobial Resistance 2011 Staphylococcus aureus Surveillance Programme. (2013) (26)
- Surveillance and reporting of antimicrobial resistance and antibiotic usage in animals and agriculture in Australia (2014) (26)
- Resistance development in community-acquired strains of methicillin-resistant Staphylococcus aureus: an in vitro study. (2004) (26)
- A community‐based intervention to reduce antibiotic use for upper respiratory tract infections in regional South Australia (2005) (26)
- Australian Group on Antimicrobial Resistance Australian Enterococcal Sepsis Outcome Programme annual report, 2014. (2016) (25)
- SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South Africa. (2003) (25)
- Antimicrobial susceptibility testing for bovine respiratory disease: getting more from diagnostic results. (2015) (25)
- Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro. (1997) (25)
- The impact of penicillin resistance on the outcome of invasive Streptococcus pneumoniae infection in children. (2000) (25)
- Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values (2018) (24)
- Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae (2016) (24)
- Is bactericidal activity of amoxicillin against Helicobacter pylori concentration dependent? (1996) (24)
- Assessing the public acceptability of proposed policy interventions to reduce the misuse of antibiotics in Australia: A report on two community juries (2017) (23)
- Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper. (2020) (23)
- Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program. (2004) (22)
- Optimum Treatment of Staphylococcal Infections (1993) (22)
- The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC (1997) (21)
- Use of In Vitro Vancomycin Testing Results To Predict Susceptibility to Oritavancin, a New Long-Acting Lipoglycopeptide (2015) (21)
- Plasmid-borne blaSHV genes in Klebsiella pneumoniae are associated with strong promoters. (2009) (21)
- VET05-R : Generation, presentation, and application of antimicrobial susceptibility test data for bacteria of animal origin : A Report (2011) (20)
- Postantibiotic Suppression of Growth of Erythromycin A-Susceptible and -Resistant Gram-Positive Bacteria by the Ketolides Telithromycin (HMR 3647) and HMR 3004 (2000) (20)
- Antimicrobial use in Australian hospitals: how much and how appropriate? (2016) (20)
- Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010. (2013) (19)
- Australian Enterococcal Sepsis Outcome Programme annual report, 2013. (2014) (19)
- Benzylpenicillin versus flucloxacillin for penicillin susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study. (2019) (19)
- Development of a Disk Diffusion Method for Testing Moraxella catarrhalis Susceptibility Using Clinical and Laboratory Standards Institute Methods: a SENTRY Antimicrobial Surveillance Program Report (2009) (19)
- A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia. (2018) (18)
- Improved Synthesis of Biotinol-5'-AMP: Implications for Antibacterial Discovery. (2015) (18)
- aac(6′)-Ib-cr Genotyping by Simultaneous High-Resolution Melting Analyses of an Unlabeled Probe and Full-Length Amplicon (2009) (18)
- Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008) (2010) (18)
- Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the Ozfoodnet Network, 2006. (2007) (18)
- Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia (2018) (16)
- Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia (2018) (16)
- Codetection of blaOXA-23-Like Gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program (2008) (16)
- Community-onset Gram-negative Surveillance Program annual report, 2012. (2014) (15)
- Selection of optimum laboratory tests for the identification of Moraxella catarrhalis (1997) (15)
- Epidemiology of quinolone resistance. Eastern hemisphere. (1995) (15)
- Activity of daptomycin against gram-positive bacterial isolates from Indian medical centres (2006-2007). (2009) (15)
- Antibiotic resistance in Streptococcus pneumoniae (2000) (14)
- Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage. (2003) (14)
- SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients (2016) (14)
- Determination of disk diffusion susceptibility testing interpretive criteria using model-based analysis: development and implementation. (2017) (13)
- Antimicrobial Use and Resistance in Australia (AURA) surveillance system: coordinating national data on antimicrobial use and resistance for Australia. (2017) (13)
- The urgent need for clear and accurate information on the polymyxins. (2013) (13)
- Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model (2017) (13)
- Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014. (2016) (13)
- Recommendations for the control of carbapenemase-producing Enterobacteriaceae (CPE): A guide for acute care health facilities: Australian Commission on Safety and Quality in Health Care (2017) (12)
- Prevalence of antimicrobial resistances in common pathogenic Enterobacteriaceae in Australia, 2004: report from the Australian Group on Antimicrobial Resistance. (2007) (12)
- Antimicrobial use and resistance in Australia. (2017) (12)
- Safety of imipenem in neonates. (1995) (11)
- Proposed method for estimating clinical cut-off (COCL) values: An attempt to address challenges encountered when setting clinical breakpoints for veterinary antimicrobial agents. (2017) (11)
- Antibiotic use or misuse? (1997) (11)
- A reappraisal of co‐trimoxazole (1988) (10)
- Breastfeeding and the risk of vertical transmission of hepatitis C virus (1995) (10)
- Inactivation, removal, and regrowth potential of opportunistic pathogens and antimicrobial resistance genes in recycled water systems. (2021) (10)
- Antibiotic prophylaxis in hysterectomy--cefotaxime compared to ampicillin-tinidazole. (1984) (10)
- Towards a Holistic, Total Engineering Cost Model (2009) (10)
- Pharmacodynamic (kinetic) considerations in the treatment of moderately severe infections with cefotaxime. (1995) (10)
- Cerebral sparganosis in an East Timorese refugee (1994) (9)
- Mutant prevention concentrations of colistin for Acinetobacter baumannii , Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates (9)
- MIC-based dose adjustment: facts and fables-authors' response. (2018) (9)
- Australian Enterococcal Sepsis Outcome Progamme, 2011. (2014) (9)
- Activity of a peptide deformylase inhibitor LBM415 (NVP PDF-713) tested against recent clinical isolates from Japan. (2005) (9)
- Commentary: what is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex? (2020) (8)
- Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance (2021) (8)
- How To: ECOFFs - the why, the how and the don´ts of EUCAST epidemiological cutoff values. (2022) (8)
- Serological investigations in the diagnosis and management of infective endocarditis. (1986) (8)
- MULTICENTRE STUDY OF THE IN VITRO ACTIVITY OF CEFEPIME, A BROAD‐SPECTRUM CEPHALOSPORIN, COMPARED TO OTHER BROAD‐SPECTRUM AGENTS (2001) (8)
- Acute Epiglottitis in Adults (1984) (8)
- Australian Group on Antimicrobial Resistance Enterococcus Surveillance Programme annual report, 2010. (2013) (7)
- Regional Resistance Surveillance Program Results for (2013) (7)
- Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters (2016) (7)
- Prediction of antibiotic dosing intervals from in vitro susceptibility, pharmacokinetics and post-antibiotic effect: theoretical considerations. (1990) (7)
- High burden of staphylococcal disease in indigenous communities. (2009) (7)
- In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens. (2009) (7)
- Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme(AESOP) Annual Report 2015. (2018) (7)
- Relative performance of antimicrobial susceptibility assays on clinical Escherichia coli isolates from animals. (2018) (7)
- Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision-authors' response. (2019) (7)
- Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility (2020) (6)
- Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility (2020) (6)
- Hospital-onset Gram-negative Surveillance Program annual report, 2011. (2014) (6)
- Cross‐border patients with tuberculosis (2011) (6)
- Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis. (2020) (6)
- Quality control ranges for tylosin 30 μg and 15 μg discs applicable to Staphylococcus aureus ATCC(R) 25923. (2014) (6)
- Low levels of fluoroquinolone resistance in Escherichia coli. A five-year trend in Australia measured through the use of TSN Database Australia. (2003) (6)
- In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (1998-1999). (2002) (6)
- β-Lactam pharmacology in liver disease (1983) (6)
- Epidemiology of Quinolone Resistance (2012) (6)
- Probenecid and food effects on flucloxacillin pharmacokinetics and pharmacodynamics in healthy volunteers. (2019) (6)
- Isoxazolyl Penicillins: Oxacillin, Cloxacillin, Dicloxacillin and Flucloxacillin (2010) (6)
- Polymyxin Susceptibility Testing and Breakpoint Setting. (2019) (5)
- TSN Database Australia, a new tool to monitor antimicrobial resistance in Australia. (2003) (5)
- The postantibiotic effect of fusidic acid against gram-positive bacteria. (1997) (5)
- Responsible Prescribing for Upper Respiratory Tract Infections (2012) (5)
- Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015. (2018) (5)
- Quality control ranges for cefoperazone 30 μg disks for Staphylococcus aureus ATCC® 25923 and Escherichia coli ATCC® 25922. (2014) (5)
- Antibiotic use in animals - Reply (2004) (5)
- Lower respiratory tract infections and community acquired pneumonia in adults. (2004) (5)
- Drug–Drug Combinations (2014) (5)
- Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971–1999 (2004) (4)
- MDRO Beijing Consensus Meeting Report: Global burden of multidrug-resistant organisms' current antimicrobial resistance problems in Asia-Pacific. (2014) (4)
- Synthesis and Antibacterial Activity of Some 'Bisquinolones' (1996) (4)
- Vancomycin vintage: my favourite DRESS (2015) (4)
- Antibiotic use in livestock. (2000) (4)
- Antimicrobial stewardship: what is it, and how does it work? (2015) (4)
- A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review. (2021) (4)
- Antibiotics in animals - much ado about something (2001) (4)
- Toxicities of flucloxacillin and dicloxacillin — is there really a difference? (2000) (4)
- Community-acquired pneumonia (2002) (4)
- Probenecid effects on cephalexin pharmacokinetics and pharmacodynamics in healthy volunteers. (2021) (4)
- Resistance sans frontières: containing antimicrobial resistance nationally and globally (2016) (4)
- Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study. (2021) (3)
- Posaconazole MIC distributions for Aspergillus fumigatus SC by four methods: Impact of Cyp51A mutations on estimation of epidemiological cutoff values (ECVs/ECOFFs) (2018) (3)
- beta-Lactam pharmacology in liver disease. (1983) (3)
- Investigation of hematuria at a printing company. (1993) (3)
- 2.2.1 Towards a Holistic, Total Engineering Cost Model (2009) (3)
- Gentamicin and ototoxicity: why this drug is still in use (2012) (3)
- Enterobacteriaceae Sepsis Outcome Programme annual report, 2013. (2014) (3)
- Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy (2022) (3)
- Pneumococcal sepsis in a neonate. (1982) (3)
- Trimethoprim, Co-Trimoxazole (Co-T) and Related Agents (2010) (3)
- Antimicrobial use and resistance in Australia (AURA): New report findings (2016) (2)
- Clinical indications treated with unregistered antimicrobials: regulatory challenges of antimicrobial resistance and access to effective treatment for patients. (2020) (2)
- Current Thinking About Pharmacokinetics and Pharmacodynamics of Antimicrobials (2000) (2)
- Developing a national surveillance system for antimicrobial use and resistance in Australia: AURA (2016) (2)
- Editorial: What to use instead of flucloxacillin (1995) (2)
- Development of Quality Control Ranges for Biocide Susceptibility Testing (2022) (2)
- Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study (2020) (2)
- Minimising inappropriate prescribing of antibiotics (2000) (2)
- Lyme disease vaccination: are we ready to try again? (2013) (2)
- Optimal Duration of Cefotaxime Prophylaxis in Abdominal and Vaginal Hysterectomy (2012) (2)
- Malaria acquired in Bali (1995) (2)
- A SURVEY OF CEPHALOSPORIN USE MONITORING USE IN A HOSPITAL SETTING (1979) (2)
- A One-Health Approach to Antimicrobial Resistance Surveillance in Australia (2014) (1)
- Antibiotic resistance : The Australian situation (1996) (1)
- Doripenem Activity Against Leading Bacterial Pathogens in the Asia-Pacific Region: Report From the SENTRY Antimicrobial Surveillance Program (2006) (2007) (1)
- A plea from EUCAST for standardization of disc susceptibility testing antimicrobial codes. (2018) (1)
- Pitfalls in antibiotic prescribing and how to avoid them. (1994) (1)
- TIME FOR A CHANGE? YES, BUT NOT TO CIPROFLOXACIN (2006) (1)
- Infectious complications of traditional Samoan tattooing. (2005) (1)
- Utilising sigmoid models to predict the spread of antimicrobial resistance at the country level (2020) (1)
- Erratum: MJA Practice Essentials - Infectious diseases 3: Community-acquired pneumonia (The Medical Journal of Australia (2002) 176 (341-347)) (2002) (1)
- An interventional program for diagnostic testing in the emergency department (2003) (1)
- Comparative macrolide use in humans and animals: should macrolides be moved off the World Health Organisation's critically important antimicrobial list? (2021) (1)
- Quantifying the impact of resistance for prescribers and drug developers-a function of natural resolution rates. (2000) (1)
- Method-dependent epidemiological cutoff values (ECVs) for detection of triazole resistance in Candida and Aspergillus species for the SYO colorimetric broth and Etest agar diffusion methods (2018) (1)
- Australian Government attempts at regulatory and other control of antimicrobial resistance (2007) (1)
- Tolerability of Roxithromycin vs Erythromycin in Comparative Clinical Trials in Patients with Lower Respiratory Tract Infections (1997) (1)
- Obituary: Johan Willem Mouton. (2019) (1)
- Antimicrobial Activity of Tigecycline Tested against Contemporary Bacterial Isolates Collected in Australia (2006) (2008) (0)
- Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective (2020) (0)
- Replacing MRSA with wild Staphylococcus aureus (1990) (0)
- surveillanCe Programme annual rePort (2014) (0)
- Minimising bacterial resistance in general practice (1997) (0)
- Factors that increase risk of community-acquired pneumonia 2-5 Age over 50 years Alcoholism Asthma Chronic obstructive pulmonary disease Dementia Heart failure Immunosuppression Indigenous background Institutionalisation Seizure disorders Smoking Stroke 2 : Chest x-ray in Streptococcus pneumoniae pn (2002) (0)
- Antimicrobial Activity of Ceftazidime Avibactam (formerly NXL104) Tested Against Gram-Negative Organisms Causing Infections in Medical Centers from Europe, Latin America and the Asia-Pacific Region (2011) (0)
- Reply to Gould (2012) (0)
- Multi-resistant Enterobacteriaceae (2008) (0)
- Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. (2023) (0)
- PRESENT STATE OF ANTIMICROBIAL RESISTANCE IN AND CONTROL OF MULTI-RESISTANT NOSOCOMIAL PATHOGENS (1996) (0)
- 40: ROBOTIC ANTIMICROBIAL SUSCEPTIBILITY PLATFORM FOR SURVEILLANCE OF ANTIMICROBIAL RESISTANCE IN SENTINEL SPECIES (2022) (0)
- Acknowledgement to reviewers (2003) (0)
- The special problem of hospital infections. (1978) (0)
- Multiresistant organisms at the front line (2010) (0)
- HIV in the suburbs (1993) (0)
- Sub-acute toxicity of colistin methanesulfonate (CMS) in rats (2006) (0)
- Standardization of antimicrobial susceptibility testing in Australia: Reinventing the wheel down under (1990) (0)
- The determination of epidemiological cut-off values requires a systematic and joint approach based on quality controlled, non-truncated minimum inhibitory concentration series. (2023) (0)
- Malaria acquired in Bali (1995) (0)
- The Wastewater Resistome of Residential Aged Care Facilities Indicates a Role of Antimicrobial Stewardship in Reducing Resistance (2022) (0)
- Disease Association of Thailand In Co-operation with Western Pacific Society of Chemotherapy International Advisory Board (2002) (0)
- soft tissue infections. Fine-needle aspiration biopsy in diagnosis of (2013) (0)
- Vertical Transmission, November 2010 (2010) (0)
- OXA- and MBL-Type Enzymes Among Uncommonly Isolated Acinetobacter Spp. in Asia-Pacific Nations: Natural Reservoir for Resistance Determinants (2008) (0)
- A multicenter evaluation of MIC distributions for ECV definition to detect (2015) (0)
- Expected phenotypes and Expert Rules are Important Complements to Antimicrobial Susceptibility Testing. (2022) (0)
- Combination Therapy Did Not Reduce 30-day Treatment Failure in Patients With Staphylococcus aureus Bacteremia (SAB) (2016) (0)
- Antibiotics for every case of otitis media? If so: which ones? (1994) (0)
- Management of Community-Acquired Pneumonia Defining the Role of Azithromycin (1999) (0)
- Prevalence and Significance of a Negative Extended-Spectrum (cid:2) -Lactamase (ESBL) Confirmation Test Result after a Positive ESBL Screening Test Result for Isolates of Escherichia coli and Klebsiella pneumoniae : Results from the SENTRY Asia-Pacific Surveillance Program (cid:1) (2007) (0)
- Vertical Transmission, September 2010 (2010) (0)
- A Guide to Selection of a Systemic Antibacterial Agent (2012) (0)
- Multicenter Retrospective Evaluation of Tigecycline Tested Against Clinical Pathogens from Japan (2003–2004) (2008) (0)
- Searching High and Low: Call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on Dosage of Antibacterial Agents in Children-Part One. (2022) (0)
- Correction: MJA Practice Essentials: Infectious diseases 3: Community-acquired pneumonia (2002) (0)
- Staphylococcus aureus bacteraemia: The Australia New Zealand Cooperative on Outcomes in Staphylococcal Sepsis (ANZCOSS) (2008) (0)
- Establishment of RCPA national guidelines for selective reporting of antimicrobials: processes, challenges and measuring the impact. (2022) (0)
- Searching high and low: Call for a joint ESPID-EUCAST survey on dosage of antibacterial agents in children - Part One. (2022) (0)
- Synthesis and Antibacterial Activity of Some “Bisquinolones”. (1996) (0)
- Atypical pneumonia. (1987) (0)
- Worldwide distribution and environmental origin of the Adelaide imipenemase (AIM-1), a potent carbapenemase in Pseudomonas aeruginosa (2021) (0)
- Steadying the ship (2011) (0)
- Activity of Tigecycline against Clinical Pathogens Collected in Indonesia (2006) (2008) (0)
- The rational prescribing of antimicrobials. (1987) (0)
- Antimicrobial Activity of Daptomycin and Comparator Agents Tested Against Gram-positive Organisms from Hong Kong, Indonesia, Philippines, Singapore and Thailand (2008) (0)
- OutcOme prOgrAmme AnnuAl repOrt, 2013 (2014) (0)
- S160 Does detection of extended-spectrum β-lactamases matter? The No case (2007) (0)
- Tigecycline Activity Against Isolates from Medical Centers Located in China, Hong Kong and Taiwan (2006): A SENTRY Antimicrobial Surveillance Program Report (2008) (0)
- Estimating the utilisation of unregistered antimicrobials in Australia. (2020) (0)
- Taking AIM-(1) at carbapenem resistance in Pseudomonas aeruginosa (2021) (0)
- The publication of studies involving the use of human critically important antimicrobial agents in veterinary species: Reply from the authors. (2021) (0)
- The publication of studies involving the use of human critically important antimicrobial agents in veterinary species. (2021) (0)
- Vertical Transmission, May 2011 (2011) (0)
- The Changing Face of Oxacillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A SENTRY Report, 1998 -2007 (2008) (0)
- Posaconazole , and Voriconazole Values for Fluconazole , Itraconazole , Distributions and Epidemiological Cutoff Study of Wild-Type Susceptibility Endpoint gattii Species Complex : an International Cryptococcus neoformans-Cryptococcus (2012) (0)
- REPLACING MRSA WITH WILD STAPHYLOCOCCUS AUREUS. REPLY (1990) (0)
- Staphylococcal infections: optimum treatment (1993) (0)
- Daptomycin Activity Tested Against Gram-positive Bacteria Isolated from Medical Centers Located in China (2006) (2008) (0)
- Prediction Model to Identify Patients at Risk of 30-Day Treatment Failure in Patients With Staphylococcus aureus Bacteremia (2016) (0)
- Responsible prescribing for URTIs (2002) (0)
- P1630 Moraxella catarrhalis susceptibility testing; development of a CLSI disc diffusion method (2007) (0)
- Letters to the Editor: Chloramphenicol for conjunctivitis (1999) (0)
- Treatment of severe meningitis due to antibiotic‐resistant Streptococcus pneumoniae (1999) (0)
- Response to letter from J Mottet "Comments on the ISCAID Guidelines on the use of antimicrobial therapies in canine superficial bacterial folliculitis". (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John D. Turnidge?
John D. Turnidge is affiliated with the following schools:
